StockData
Tandem Diabetes Care Inc logo

Tandem Diabetes Care Inc (TNDM) stock

TNDMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3030% below fair value
$17.05−0.01 (-0.06%)

Close on Nov 18, 2026Market cap $1.19BP/E –Yield –

Tandem Diabetes Care operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Tandem Diabetes Care's operating income for the twelve months ending Jun 30, 2026 was -$45.80M. For fiscal 2025 it was -$187.26M. The highest annual figure on record is $22.65M in fiscal 2021.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$187.26M–
FY2024Dec 31, 2024-$99.13M–
FY2023Dec 31, 2023-$233.23M–
FY2022Dec 31, 2022-$92.85M-509.9%
FY2021Dec 31, 2021$22.65M–
FY2020Dec 31, 2020-$7.96M–
FY2019Dec 31, 2019-$16.72M–
FY2018Dec 31, 2018-$44.63M–
FY2017Dec 31, 2017-$62.94M–
FY2016Dec 31, 2016-$78.05M–
FY2015Dec 31, 2015-$69.00M–
FY2014Dec 31, 2014-$75.66M–
FY2013Dec 31, 2013-$49.43M–
FY2012Dec 31, 2012-$33.05M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$13.79M–
Q1 FY2026Mar 31, 2026-$17.43M–
Q4 FY2025Dec 31, 2025$8.29M–
Q3 FY2025Sep 30, 2025-$22.86M–
Q2 FY2025Jun 30, 2025-$51.81M–
Q1 FY2025Mar 31, 2025-$120.88M–
Q4 FY2024Dec 31, 2024-$581.00K–
Q3 FY2024Sep 30, 2024-$26.09M–
Q2 FY2024Jun 30, 2024-$30.77M–
Q1 FY2024Mar 31, 2024-$41.68M–
Q4 FY2023Dec 31, 2023-$35.06M–
Q3 FY2023Sep 30, 2023-$31.55M–
Q2 FY2023Jun 30, 2023-$38.81M–
Q1 FY2023Mar 31, 2023-$127.82M–
Q4 FY2022Dec 31, 2022-$17.78M-239.6%
Q3 FY2022Sep 30, 2022-$47.49M-715.2%
Q2 FY2022Jun 30, 2022-$12.24M-325.3%
Q1 FY2022Mar 31, 2022-$15.34M–
Q4 FY2021Dec 31, 2021$12.74M-31.7%
Q3 FY2021Sep 30, 2021$7.72M–
Q2 FY2021Jun 30, 2021$5.43M–
Q1 FY2021Mar 31, 2021-$3.24M–
Q4 FY2020Dec 31, 2020$18.66M+770.4%
Q3 FY2020Sep 30, 2020-$1.01M–
Q2 FY2020Jun 30, 2020-$12.04M–
Q1 FY2020Mar 31, 2020-$13.57M–
Q4 FY2019Dec 31, 2019$2.14M+282.9%
Q3 FY2019Sep 30, 2019-$6.00M–
Q2 FY2019Jun 30, 2019-$1.87M–
Q1 FY2019Mar 31, 2019-$11.00M–
Q4 FY2018Dec 31, 2018$560.00K–
Q3 FY2018Sep 30, 2018-$15.71M–
Q2 FY2018Jun 30, 2018-$14.00M–
Q1 FY2018Mar 31, 2018-$15.49M–
Q4 FY2017Dec 31, 2017-$9.58M–
Q3 FY2017Sep 30, 2017-$13.17M–
Q2 FY2017Jun 30, 2017-$18.97M–
Q1 FY2017Mar 31, 2017-$21.23M–
Q4 FY2016Dec 31, 2016-$13.35M–
Q3 FY2016Sep 30, 2016-$28.41M–

More Tandem Diabetes Care figures

See a number that looks wrong?